Mitochondria Delivery via Extracellular Vesicles to the Blood-Brain Barrier
Dr. Devika S Manickam, Duquesne University, USA, and active member of the WMS Scientific Committee will be joining Targeting Mitochondria 2024 this October in Berlin.
Presentation title: Mitochondria Delivery via Extracellular Vesicles to the Blood-Brain Barrier
Highlights
- Role of extracellular vesicles (EVs) in intercellular communication and drug delivery.
- Incorporation of mitochondria small EVs (<200 nm) and medium-to-large EVs (m/lEVs >200 nm) EVs during biogenesis.
- Potential of m/lEVs to deliver healthy mitochondria for treating neurodegenerative, cardiovascular, and metabolic diseases.
- Advantage of m/lEVs using endogenous mechanisms for cellular repair.
- Impact of ischemic stroke on mitochondrial function in blood-brain barrier endothelial cells.
- Efficacy of human brain endothelial cells (BEC) -derived mitochondria-containing EVs in mouse stroke models.
- Improved therapeutic outcomes with species-specific EVs (mouse BEC-EVs) in stroke models.
- Support for using m/lEVs to enhance therapeutic potential in preclinical studies.
World Mitochondria Society
Annual World Congress on Targeting Mitochondria
LinkedIn | Facebook
